A Randomized Phase III Trial of Vinorelbine Versus Gemcitabine and Carboplatin for Elderly Patients With Advanced Non-Small Cell Lung Cancer
Interventional
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Young Jin Yuh, M.D.
Principal Investigator
Korea: Food and Drug Administration
INJE05-06
NCT00265694
Name | Location |
---|